Experimental Blood Thinner Given Before Surgery Shows Benefit - Health News - Health.com
Latest news:
TUESDAY, Jan. 17 (HealthDay Intelligence) — An data-based anti-blood-clotting dose can process as a transposition for otc drugs such as Plavix in the years earlier pump operation, a new discipline has plant.
The endovenous dose cangrelor appears to get the voltage to attend as a “span” medicament for pump patients to return in the various years ahead procedures such as coronary arteria ringway graft, the work authors reported.
Anti-clotting drugs, likewise referred to as antiplatelet therapy or anticoagulants — including clopidogrel, known by the steel diagnose Plavix — are much granted to pump patients to forbid grievous vessel-clogging origin clots. But they can drive too lots hemorrhage during operation, and guidelines propose that doctors stoppage intervention with them in the 5 to sevener years earlier an performance.
In the new bailiwick, Dr. Dominick Angiolillo of the University of Florida, Jacksonville, and colleagues gave cangrelor or a placebo to 210 patients who were some to undergo coronary arteria beltway graft. The patients had been hardened with a thienopyridine (such as Plavix) but went off the drugs anterior to operation as recommended, so standard cangrelor or placebo for at least 48 hours until one to six hours ahead or.
Angiolillo’s squad ground that overweening hemorrhage related to or wasn’t practically more belike in the patients who took the dose (11.8 percentage) compared to those who took the placebo (10.4 pct). Major hemorrhage problems ahead or were rarefied, spell those who took cangrelor had more kid hemorrhage problems, according to the study promulgated in the Jan. 18 publication of the Journal of the American Aesculapian Tie.
The investigators likewise institute that the patients who took cangrelor reached levels of thrombocyte suppression that are joined to a frown hazard of problems such as clots.
The findings brand smell, aforesaid Dr. Gregg Gemstone, a pump specializer and prof of medicate at Columbia University in New York Metropolis. The cogitation shows that cangrelor plant quickly and so dissipates when it isn’t needful anymore so it doesn’t encouragement the jeopardy of haemorrhage during operation, he aforementioned.
“This dose is investigational, so it is not yet an selection for patients to ask almost,” Lapidate pointed out, “but if [the U.S. Nutrient and Dose Government] sanctioned it, it would potential be wide exploited.”
For more most line thinners, chit-chat the U.S. Interior Library of Music.
SOURCES: Gregg W. Gemstone, M.D., prof, medication, Columbia University, New York Metropolis; Jan. 18, 2012, Journal of the American Aesculapian Connection
Copyright © 2012 HealthDay. All rights reserved.
